100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Previously searched by you
Previously searched by you
logo
Test Bank for Applied Pharmacology for The Dental Hygienist 9th Edition by Elena Bablenis Haveles, All Chapter 1-26, A+ guide. 9780323798631 $26.49
Add to cart
Quickly navigate to
Preview
  2.  
  3. Nursing
  4.  
  5. Nursing

Exam (elaborations)

Test Bank for Applied Pharmacology for The Dental Hygienist 9th Edition by Elena Bablenis Haveles, All Chapter 1-26, A+ guide. 9780323798631
 0 purchase
  • Course
  • Nursing
  • Institution
  • Nursing

Test Bank for Applied Pharmacology for The Dental Hygienist 9th Edition by Elena Bablenis Haveles, All Chapter 1-26, A+ guide. 9780323798631

Preview 4 out of 438  pages

Document information

  • October 18, 2024
  • 438
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers

Subjects

  • test bank for applied pharmacology for the dental

Written for

  • Nursing
  • Nursing

Seller

avatar-seller
Spencejames

Reviews received

Content preview

Applied Pharmacology for The Dental Hygienist 9th
| | | | | |




Edition by Elena Bablenis Haveles
| | | | |




Complete Test Bank
| |

,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and Prescription
| | | | | | | | |

Writing
|


Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
| | | | | | | |




MULTIPLE |CHOICE

1. Knowledge |of |pharmacology |aids |the |dental |professional |in
a. obtaining |a |patient’s |health |history.
b. administering |drugs |in |the |office.
c. handling |emergency |situations.
d. selection |of |a |nonprescription |medication.
e. All |of |the |above.
ANS: | E
All |of |the |choices |are |true. |Because |many |of |our |patients |are |being |treated |with |drugs, |knowledge |of
|pharmacology |helps |in |understanding |and |interpreting |patients’ |responses |to |health |history |questions.

|Knowledge |of |the |therapeutic |and |adverse |effects |of |medications |obviously |helps |in |their |proper

|administration |in |the |office. |Emergency |situations |may |be |caused |by |drugs |or |treated |by |drugs; |thus,

|knowledge |of |pharmacology |is |of |great |help, |especially |because |a |rapid |response |is |sometimes

|required. |A |clear |understanding |of |the |concepts |of |drug |action, |drug |handling |by |the |body, |and |drug

|interactions |will |allow |the |dental |practitioner |to |make |proper |judgments |and |grasp |the |concepts

|relevant |to |new |drug |therapies |on |the |market.




DIF: Application
REF: | Role |of |the |Dental |Hygienist |(Medication/Health |History), |Role |of |the |Dental |Hygienist
|(Medication |Administration), |Role |of |the |Dental |Hygienist |(Emergency |Situations), |Role |of |the |Dental

|Hygienist |(Nonprescription |Medication) || |pp. |2-3 OBJ: 1
TOP: | NBDHE, |6.0. |Pharmacology

2. Which |of |the |following |statements |is |true |regarding |planning |appointments?
a. Whether |or |not |patients |are |taking |medication |for |systemic |diseases |is |of
little
|

consequence |in |the |dental |office.
b. Asthmatic |patients |should |have |dental |appointments |in |the |morning.
c. Diabetic |patients |usually |have |fewer |problems |with |a |morning |appointment
|compared |with |afternoon |appointments.

d. Both |B |and |C |are |true.
ANS: | D
Asthmatic |patients |who |experience |dental |anxiety |should |schedule |their |appointments |when |they |are
|not |rushed |or |under |pressure |early |in |the |morning. |Diabetic |patients |usually |have |relatively |fewer

|problems |with |a |morning |appointment. |Patients |taking |medication |for |systemic |diseases |may |require

|special |handling |in |the |dental |office.




DIF: Comprehension
REF: | Role |of |the |Dental |Hygienist |(Appointment |Scheduling) ||
|p. |3 |OBJ: | 1 TOP: | NBDHE, |6.0. |Pharmacology

,3. Nutritional |or |herbal |supplements
a. carry |the |U.S. |Food |and |Drug |Administration |(FDA) |approval |for |disease
states.
|

b. are |not |drugs.
c. can |cause |adverse |effects.
d. will |not |interact |with |other |drugs |the |patient |may |be |taking.
ANS: | C
Nutritional |or |herbal |supplements |are |quite |capable |of |causing |adverse |effects. |The |majority |of
|nutritional |or |herbal |supplements |do |not |carry |FDA |approval |for |treating |disease |states. |These

|supplements |are |drugs |and |can |cause |adverse |effects |and |interact |with |different |drugs.




DIF: Comprehension
REF: | Role |of |the |Dental |Hygienist |(Nutritional |or |Herbal |Supplements) ||
|p. |3 |OBJ: | 1 TOP: | NBDHE, |6.0. |Pharmacology

4. Which |type |of |drug |name |usually |begins |with |a |lowercase |letter?
a. Brand |name
b. Code |name
c. Generic |name
d. Trade |name
ANS: | C
Before |any |drug |is |marketed, |it |is |given |a |generic |name |that |becomes |the |“official” |name |of |the |drug.
|Each |drug |is |assigned |only |one |generic |name |selected |by |the |U.S. |Adopted |Name |Council, |and |the

|name |is |not |capitalized. |The |brand |name |is |equivalent |to |the |trade |name |and |is |capitalized.

|Although |the |brand |name |is |technically |the |name |of |the |company |marketing |the |product, |this |term |is

|often |used |interchangeably |with |the |trade |name. |The |code |name |is |the |initial |term |used |within |a

|pharmaceutical |company |to |refer |to |a |drug |while |it |is |undergoing |investigation |and |is |often |a

|combination |of |capital |letters |and |numbers, |the |letters |representing |an |abbreviation |of |the |company

|name.




DIF: Comprehension REF: | Drug |Names || |p.
|4 |OBJ: | 3 TOP: | NBDHE, |6.0. |Pharmacology

5. A |drug’s |generic |name |is |selected |by |the
a. pharmaceutical |company |manufacturing |it.
b. Food |and |Drug |Administration |(FDA).
c. U.S. |Adopted |Name |Council.
d. Federal |Patent |Office.
ANS: | C
Each |drug |is |assigned |only |one |generic |name |(e.g., |ibuprofen). |It |is |selected |by |the |U.S. |Adopted
|Name |Council. |The |generic |name |is |not |selected |by |the |FDA |or |the |Federal |Patent |Office. |The

|pharmaceutical |company |manufacturing |the |drug |clearly |has |an |influence |on |the |generic |name |given

|its |drug, |but |the |final |decision |is |not |the |company’s.




DIF: Recall REF: | Drug |Names || |p. |4 OBJ:
| 3 |TOP: | NBDHE, |6.0. |Pharmacology




6. Which |of |the |following |is |true |concerning |generic |and |trade |names |of |drugs?
a. A |drug |may |only |have |one |generic |name |and |one |trade
name.
|

, b. A |drug |may |only |have |one |generic |name, |but |it |may |have |several |trade
names.
|

c. A |drug |may |have |several |generic |names, |but |it |may |only |have |one |trade
|name.

d. A |drug |may |have |several |generic |names |and |several |trade |names.
ANS: | B
Each |drug |has |only |one |generic |name |but |may |have |several |trade |names. |For |each |drug, |there |is |only
|one |generic |name. |It |is |not |capitalized, |and |it |becomes |the |“official” |name |of |the |drug. |The

|pharmaceutical |company |discovering |the |drug |gives |the |drug |a |trade |name. |The |trade |name |is

|protected |by |the |Federal |Patent |Law |for |20 |years |from |the |earliest |claimed |filing |date, |plus |patent

|term |extensions. |Although |the |brand |name |is |technically |the |name |of |the |company |marketing |the

|product, |it |is |often |used |interchangeably |with |the |trade |name.




DIF: Comprehension REF: | Drug |Names || |p.
|4 |OBJ: | 3 TOP: | NBDHE, |6.0. |Pharmacology

7. Two |drugs |that |are |found |to |be |chemically |equivalent, |but |not |biologically |equivalent |or
therapeutically |equivalent |are |said |to |differ |in
|

a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic |index.
ANS: | C
A |preparation |can |be |chemically |equivalent |yet |not |biologically |or |therapeutically |equivalent. |These
|products |are |said |to |differ |in |their |bioavailability. |The |potency |of |a |drug |is |a |function |of |the |amount

|of |drug |required |to |produce |an |effect. |The |efficacy |is |the |maximum |intensity |of |effect |or |response

|that |can |be |produced |by |a |drug. |The |therapeutic |index |is |the |ratio |of |the |lethal |dose |for |50% |of |the

|experimental |animals |divided |by |the |effective |dose |for |50% |of |the |experimental |animals. |If |the

|value |of |the |therapeutic |index |is |small, |toxicity |is |more |likely.




DIF: Recall REF: | Drug |Names |(Drug |Substitution) || |p.
|5 |OBJ: | 4 TOP: | NBDHE, |6.0. |Pharmacology

8. How |many |years |must |pass |after |a |drug |patent |expires |before |other |drug |companies |can |market
the |same |compound |as |a |generic |drug?
|

a. 20 |years
b. 17 |years
c. 7 |years
d. 0 |years
ANS: | D
Once |a |drug |patent |expires, |competing |companies |may |immediately |market |the |same |compound |in
|generic |form. |The |pharmaceutical |company |discovering |the |drug |gives |the |drug |a |trade |name. |The

|trade |name |is |protected |by |the |Federal |Patent |Law |for |20 |years |from |the |earliest |claimed |filing |date,

|plus |the |patent |term |extensions.




DIF: Application REF: | Drug |Names |(Drug |Substitution) || |p.
|5 |OBJ: | 4 TOP: | NBDHE, |6.0. |Pharmacology

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Spencejames. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $26.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

64302 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 15 years now

Start selling

Recently viewed by you

Exam (elaborations) ·

(0)

TEST BANK For Nursing Delegation and Management of Patient Care, 3rd Edition by Motacki | Verified Chapters 1 - 21 | Complete Newest Version

Exam (elaborations) ·

(0)

Test Bank For Nursing Theories and Nursing Practice 5th Edition By Marlaine C. Smith ISBN 9780803679917 Chapter 1-33 | Complete Guide A+

Exam (elaborations) ·

(0)

APOLOGETICS EXAM NEWEST 2024 ACTUAL EXAM ALL QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES (VERIFIED ANSWERS) |ALREADY GRADED A+

Exam (elaborations) ·

(0)

TEST BANK For Physical Examination and Health Assessment 8th Edition, by Carolyn Jarvis, Verified Chapters 1 - 32, Complete Newest Version

Summary ·

(0)

Samenvatting Handboek methodische ouderbegeleiding 2 - Handboek Methodische Ouderbegeleiding 2 naar een psychologie van ouderschap - Ouderschap

Exam (elaborations) ·

(2)

Test Bank for Maternal Child Nursing, 5th Edition, Emily Slone McKinney, Susan R. James, Sharon Smith Murray, Kristine Nelson, Jean Ashwill

Summary ·

(1)

Summary BUS 209 FINAL EXAM STUDY GUIDE 21questions written by Lucas BUS 209: Written Communication in Business Study Questions Answers

Exam (elaborations) ·

(0)

ATI RN Mental Health Online Practice 2019 B (Retake 2023) Questions with All Correct Answers| Rationale in All Choices |Guarantee A+ Score Guide

Exam (elaborations) ·

(0)

Solutions Manual for Auditing A Practical Approach With Data Analytics 2nd Edition By Raymond Johnson, Laura Davis Wiley, Robyn Moroney
$26.49
  • (0)
Add to cart
Added